359674468	359674468	CD	B-NP	O
|	|	NN	I-NP	O
SVH	SVH	NN	I-NP	O
|	|	NN	I-NP	O
81144666	81144666	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
680976	680976	CD	B-NP	O
|	|	CC	I-NP	O
10/17/1997	10/17/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
AVASCULAR	AVASCULAR	NNP	I-NP	O
NECROSIS	NECROSIS	NNP	I-NP	O
RT.	RT.	NNP	I-NP	O
.	.	.	O	O

HIP	HIP	NN	B-NP	B-protein
|	|	VBZ	B-VP	O
Signed	Signed	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/16/1997	6/16/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/1/1997	6/1/1997	CD	B-NP	O
FINAL	FINAL	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OSTEONECROSIS	OSTEONECROSIS	NN	I-NP	O
OF	OF	IN	B-PP	O
RIGHT	RIGHT	NN	B-NP	B-protein
HIP	HIP	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
PAROXYSMAL	PAROXYSMAL	NN	I-NP	O
SUPRAVENTRICULAR	SUPRAVENTRICULAR	NN	I-NP	O
TACHYCARDIA	TACHYCARDIA	NN	I-NP	O
PROCEDURE	PROCEDURE	NN	I-NP	O
:	:	:	O	O
RIGHT	RIGHT	NN	B-NP	O
TOTAL	TOTAL	NN	I-NP	O
HIP	HIP	NN	I-NP	O
REPLACEMENT	REPLACEMENT	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73	73	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
sided	sided	JJ	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
approximately	approximately	RB	B-NP	O
four	four	CD	I-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
severely	severely	RB	B-VP	O
limited	limit	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
ambulation	ambulation	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
activities	activity	NNS	B-NP	O
of	of	IN	B-PP	O
daily	daily	JJ	B-NP	O
living	living	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	B-protein
right	right	JJ	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
radiographs	radiograph	NNS	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
osteonecrosis	osteonecrosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
or	or	CC	I-NP	O
steroid	steroid	NN	I-NP	O
boluses	bolus	NNS	I-NP	O
or	or	CC	O	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Degenerative	Degenerative	JJ	B-NP	O
joint	joint	JJ	I-NP	O
disease	disease	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
hands	hand	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
varicose	varicose	NN	I-NP	O
vein	vein	NN	I-NP	O
stripping	stripping	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
cataract	cataract	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Voltaren	Voltaren	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Cimetidine	Cimetidine	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Permatol	Permatol	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Levoxil	Levoxil	NNP	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
antalgic	antalgic	JJ	I-NP	O
gait	gait	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
dentures	denture	NNS	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Infrequent	Infrequent	JJ	B-NP	O
ectopic	ectopic	JJ	I-NP	O
beats	beat	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
sensation	sensation	NN	I-NP	O
and	and	CC	I-NP	O
motor	motor	NN	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
degree	degree	NN	I-NP	O
straight	straight	JJ	I-NP	O
leg	leg	NN	I-NP	O
raise	raise	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
flexion	flexion	NN	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
internal	internal	JJ	B-NP	O
rotation	rotation	NN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
degrees	degree	NNS	I-NP	O
of	of	IN	B-PP	O
external	external	JJ	B-NP	O
rotation	rotation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
X-rays	X-ray	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
collapse	collapse	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
head	head	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
osteonecrosis	osteonecrosis	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
old	old	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
scan	scan	NN	I-NP	O
also	also	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
these	these	DT	B-NP	O
osteonecrotic	osteonecrotic	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
head	head	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
10/16/97	10/16/97	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
details	detail	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PCA	PCA	NN	I-NP	B-protein
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
adequate	adequate	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
blood	blood	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
postoperative	postoperative	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
29	29	CD	B-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
transfusions	transfusion	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
was	be	VBD	B-VP	O
35.4	35.4	CD	B-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
numerous	numerous	JJ	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
medicine	medicine	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
be	be	VB	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
at	at	IN	B-PP	O
first	first	JJ	B-ADJP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
her	her	PRP$	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Verapamil	Verapamil	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
her	her	PRP	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
supraventricular	supraventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
progress	progress	VB	I-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
CK	CK	NN	I-NP	B-protein
and	and	CC	I-NP	O
MB	MB	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Hemovac	Hemovac	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
wound	wound	NN	I-NP	O
inspected	inspect	VBN	B-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
and	and	CC	O	O
thereafter	thereafter	RB	O	O
her	her	PRP$	B-NP	O
incision	incision	NN	I-NP	O
remained	remain	VBD	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
or	or	CC	I-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
worked	work	VBD	B-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
daily	daily	JJ	I-NP	O
basis	basis	NN	I-NP	O
and	and	CC	O	O
progressed	progress	VBD	B-VP	O
well	well	RB	B-ADVP	O
once	once	RB	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
working	work	VBG	I-VP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
progressing	progress	VBG	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
supraventricular	supraventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
down	down	IN	B-ADVP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
90s	90	NNS	I-NP	I-DNA
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
incision	incision	NN	I-NP	O
appeared	appear	VBD	B-VP	O
clean	clean	JJ	B-NP	O
,	,	,	I-NP	O
dry	dry	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
non-invasive	non-invasive	JJ	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
hip	hip	NN	I-NP	O
film	film	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
non-invasive	non-invasive	JJ	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Locke	Locke	NNP	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
cal	cal	VB	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
room	room	NN	B-NP	O
permits	permit	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Captopril	Captopril	NNP	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
Lopressor	Lopressor	NN	B-NP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
sole	sole	JJ	I-NP	O
agent	agent	NN	I-NP	O
for	for	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Captopril	Captopril	NNP	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Levoxil	Levoxil	NNP	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q6h	q6h	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
sublingual	sublingual	JJ	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q4h	q4h	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dosed	dose	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
in	in	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
between	between	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
remain	remain	VB	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Cimetidine	Cimetidine	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
Dictated	Dictated	NNP	B-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CLAUDE	CLAUDE	NNP	B-NP	O
MCRAVEN	MCRAVEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GP3	GP3	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EMIL	EMIL	NNP	B-NP	O
F.	F.	NNP	I-NP	O
PUCHALLA	PUCHALLA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
OT85	OT85	NNP	I-NP	O
US789/1073	US789/1073	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
5434	5434	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

PNVZ3499MG	PNVZ3499MG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/5/97	5/5/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/5/97	5/5/97	CD	B-NP	O

